Hyperhomocysteinaemia is generally accepted as an independent and graded risk factor for both arterial occlusive disease and venous thrombosis. The only way of homocysteine degradation is conversion to cysteine in the transsulfuration pathway in which the regulating step is catalysed by cystathionine bsynthase (CBS). Mild impairment of CBS function could therefore affect homocysteine concentration, in particular after methionine loading, and consequently cardiovascular disease (CVD) risk. We analysed two silent polymorphisms and one short tandem repeat in the CBS gene (ie 699C?T, 1080C?T and -5697 (GT) STR) as genetic markers potentially in linkage disequilibrium with a functional polymorphism. We assessed their association with fasting and post-methionine load homocysteine in 190 patients with arterial occlusive disease, and in 381 controls. No differences in CBS genotype frequencies between cases and controls were found, nor was a particular CBS genotype associated with an elevated risk of arterial occlusive disease. Although we did find a high rate of linkage disequilibrium between the two single nucleotide polymorphisms and the GT STR, none of the genotypes defined by the three CBS variants studied showed an association with elevated fasting, post-load or increase upon methionine loading homocysteine concentrations. In conclusion, we did not find any indication that genetic variation in the CBS gene is associated with increased homocysteine concentrations.
Introduction
Established risk factors for cardiovascular disease (CVD) include elevated blood cholesterol, hypertension, diabetes mellitus and tobacco smoking. A modest elevation of plasma homocysteine concentration, commonly referred to as hyperhomocysteinemia, is generally, 1,2 though not universally 3, 4 accepted as an independent and graded risk factor for both arterial occlusive diseases and venous thrombosis. 5, 6 Homocysteine, an intermediate sulfur amino acid in methionine metabolism, may either be irreversibly degraded to cysteine via cystathionine in the transsulfuration pathway or remethylated to methionine. The remethylation by methionine synthase requires 5-methyltetrahydrofolate for methyl donation and vitamin B12 for methyl transport, while the remethylation by betainehomocysteine-methyltransferase requires betaine as methyl donor. The regulating step in the transsulfuration pathway is catalysed by cystathionine b-synthase (CBS), a pyridoxal 5'-phosphate-dependent enzyme. The inherited metabolic disorder CBS deficiency is acknowledged to be the most frequent cause of homocystinuria in humans.
CVD patients. This was based on the decreased CBS activities they found in extracts of cultured fibroblasts of hyperhomocysteinaemic vascular disease patients and their increased post-methionine loading homocysteine concentrations, both resembling those of obligate heterozygotes for CBS deficiency. Similar results were described by Clarke et al. 9 Both studies however, do not reconcile with an earlier observation by Mudd et al, 10 who described a similar incidence of heart attacks or strokes in parents and grandparents of homocystinuric children compared with relatives of children with either new-mutation achondroplastic dwarfism or with impaired phenylalanine metabolism. Furthermore, the finding of decreased CBS activities in cultured fibroblasts from hyperhomocysteinaemic vascular disease patients in the range of obligate heterozygotes could not be reproduced by us, 11, 12 and still needs clarification. In addition to fasting homocysteine concentrations, also post-methionine load homocysteine concentrations were found to be correlated among family members of patients with hyperhomocysteinaemia and vascular disease. 13 -15 So, it can be concluded that hyperhomocysteinaemia is, at least partially, genetically based. Still, elevated post-methionine load homocysteine concentrations are associated with increased CVD risk, 16 -18 but its genetic determinants remain obscure. Over 100 mutations have been described in the CBS gene in classical homocystinuria patients. 19 A 68 bp insertion in exon 8, first reported as a causal mutation in an Italian patient, was found to be polymorphic and not to be associated with plasma homocysteine concentrations. 20, 21 No other potentially functional polymorphisms associated with elevated homocysteine levels were detected in the CBS gene in the analyses of the genetic basis of homocystinuria. However, most studies performed thus far only examined the coding region of the CBS gene, leaving the non-coding regions unexplored. Very recently, we described an inverse correlation between the number of tandem repeats defined by a 31 bp VNTR (variable number of tandem repeats), 22 and CBS enzyme activities in fibroblasts. 23 Furthermore, a positive association was observed between the number of repeat units and post-methionine load plasma homocysteine concentrations. 23 Genetic association studies are widely used for the identification of candidate genes of complex, ie non-mendelian traits. 24 In such studies, the association is investigated between a phenotype and genomic markers close to or, preferably, within the gene of interest. Such a marker in itself is not necessarily functionally related to the phenotype but may be in linkage disequilibrium with a functional variant.
In the present study, we investigated the potential involvement of genetic variants in non-coding regions or of silent mutations in the CBS gene in hyperhomocysteinaemia and vascular disease, as possible markers which may be in linkage disequilibrium with a functional polymorphism. We analysed two silent single nucleotide polymorphisms (699C?T, 1080C?T) and a short tandem repeat (STR) -5697(GT), 22 in the CBS gene in 190 vascular disease patients and in 381 population-based controls. We report the allele frequencies and genotype distributions of these polymorphic variants in both study groups, and describe their association with fasting, post-methionine load and delta (ie increase upon methionine loading) plasma homocysteine concentrations. Also, the extent of linkage disequilibrium between the several CBS variants are calculated.
Materials and methods

Study population
We studied 190 patients with coronary, peripheral or cerebral vascular disease; a total of 130 cases were recruited from a cohort of patients who underwent coronary angiography in the Zuiderziekenhuis Hospital in Rotterdam, The Netherlands. 18 Reasons for angiography were myocardial infarction or angina pectoris and cases were defined as those having 590% occlusion in one and 540% occlusion in one additional coronary artery. The other 60 patients had documented premature cardiovascular disease of which 10 patients had suffered from myocardial infarction, 32 from cerebral arterial occlusive disease and 18 from peripheral arterial occlusive disease.
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The control group consisted of 381 controls, of whom 101 were included from the general population in Rotterdam and comprised subjects with no history of cardiovascular disease 18 and 280 were recruited from a general practice in The Hague, The Netherlands to take part in a health survey. 25 
Biochemical parameters
After an overnight fast, blood was collected in EDTA tubes for measurement of fasting total homocysteine. The EDTA-blood samples were placed on ice immediately, and centrifuged for 10 min at 3000 g with minimal delay. All individuals were subjected to a standardised methionine loading test. 26 Briefly, L-methionine (0.1 g/kg body weight) was dissolved in 200 mL orange juice and administered orally. All study subjects received a standardised low protein breakfast and luncheon, and were asked not to consume any milk-containing beverages. After 6 h, another blood sample was drawn for assessment of the post-methionine load homocysteine concentration. Total homocysteine was measured in plasma using a high-performance liquid chromatography (HPLC) procedure, with reverse phase separation and fluorescence detection, as described by Te Poele-Pothoff et al. 27 All homocysteine measurements were conducted at the University Medical Center Nijmegen, The Netherlands, and fasting and post-load plasma homocysteine levels were obtained from 555 and 525 individuals, respectively.
Detection of CBS polymorphisms
Genomic DNA was isolated from buffy coats of EDTA blood by a standard method, 28 and stored at 48C until analysis.
Genomic DNA was available from 561 individuals.
699C?T transition
This polymorphism does not create a restriction enzyme recognition site, and was therefore analysed by Primer Introduced Restriction Analysis. A mutagenic sense oligonucleotide (5'-CAGCAACCCCCTGGCTCAGT-3') introduces a RsaI site in the 699C allele and together with an antisense oligonucleotide (5'-TTATCGTTTGTGTCCCGTACCG-3') a genomic DNA fragment of 287 bp was amplified using approximately 100 ng genomic DNA and 100 ng of both oligonucleotides in a standard PCR buffer (10 
1080C?T transition
A genomic DNA fragment of 88 bp was amplified by PCR using both 100 ng forward (5'-CTGGCAGCACGGTGGC-GG-3') and 100 ng reverse oligonucleotides (5'-CGCACTG-AGTCGGGCAGAATG-3'), and approximately 100 ng genomic DNA in a standard PCR buffer (10 mM Tris-HCl, pH 8.3; 50 mM KCl) containing 2 mM MgCl 2 and 200 mM dNTPs. All samples were cycled 35 times: 1 min /928C denaturation, 1 min/558C annealing, 30 s/728C extension, preceded by an initial denaturation of 3 min/928C and followed by a final extension of 7 min/728C. The PCR fragment was analysed by BstUI restriction enzyme analysis followed by separation on a 2% agarose gel. The 1080 TT genotype results in an uncut fragment of 88 bp, the 1080 CC genotype in two fragments of 55 and 33 bp, whereas the heterozygous CT genotype is displayed by three fragments (88, 55, and 33 bp).
(GT) STR
A PCR was performed with a 5'FAM labelled forward primer (5'-GAGCTGAAATCACACCACT-3') and a reverse primer (5'-GTTTTTACTACATTTGCTCCC-3') in a standard PCR buffer containing 2 mM MgCl 2 and using an annealing temperature of 588C. The 193 -211 bp fluorescently labelled PCR products were separated on a 4% denaturating polyacrylamide gel using the ABI Prism 377, according to the manufacturer's recommendations. Data-analysis was performed using the Genescan and Genotyper Software (Perkin Elmer).
Statistical analysis
Plasma homocysteine concentrations showed positive skewness, therefore log-transformed homocysteine levels were used in all analyses. Differences in genotype distributions, allele frequencies and gender were assessed by Pearson's w 2 analysis. Differences in continuous variables between cases and controls were assessed by Student's t-test, adjusted for age and gender by means of linear regression analysis. One-way analysis of variance (ANOVA) was used to assess the differences of continuous variables between different genotypes, followed by Bonferroni-corrected t-tests. Odds ratios (OR) and 95% confidence intervals (95% CI) as estimates of the relative risk for arterial occlusive disease for the different CBS genotypes, were calculated with logistic regression analysis. We also investigated the association between these three genetic variants and the 31 bp VNTR, of which alleles 19 and 21 were shown to be associated with increased post-methionine load homocysteine concentrations. 23 The haplotype frequencies and linkage disequilibria were estimated by the EH program.
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reflects the extent of the linkage disequilibrium, which is reported as the ratio between the actual value of D (ie the departure from linkage disequilibrium) and the maximum value it can have for the given allele frequencies. The sign in front of the coefficients indicates whether the rare alleles are associated (+) or the rare allele is associated with the frequent allele (7). All P-values reported are two-tailed, and statistical significance was accepted at P50.05.
Results Table 1 depicts age, gender, and total plasma homocysteine concentrations (ie fasting, post methionine load, and net increase upon methionine loading) of cases and controls. Age, expressed as the geometric mean, and the percentage males did not differ between the two groups. A higher fasting homocysteine (+7.5%; P=0.011) and post-methionine loading homocysteine concentration (+5.6%; P=0.045) was seen in cases compared with controls. Cases and controls showed a comparable net increase upon methionine loading (ie post-load minus fasting homocysteine concentration).
Both 699C?T, 1080C?T as well as the GT STR genotype distributions were in Hardy-Weinberg equilibrium (data not shown). Genotype distributions for each of the three CBS polymorphisms were similar in cases and controls ( Table  2 , left side). The allele frequency of the 699T allele was 0.37 and 0.35 in patients and controls, respectively (w 2 =0.30, P=0.58); the 1080T allele had an allele frequency of 0.32 in patients and of 0.37 in controls (w 2 =2.89,
P=0.09).
In our study population, we identified 10 different alleles defined by the highly polymorphic GT STR (which were named after the number of repeat units) that led to the observation of 22 different genotype combinations (Table 2) . CBS genotypes were investigated as risk factors for arterial occlusive disease. The differences in CBS genotype frequencies between the case and control group were not statistically significant ( In addition, the association between CBS genotypes and fasting and post-load plasma homocysteine concentrations was studied (Table 2 , right side). We combined cases and controls to increase statistical power, since associations between CBS genotypes and plasma homocysteine did not differ between cases and controls (all P-values 40.14). For the 699C?T polymorphism no differences in fasting, post-load or delta homocysteine concentrations were observed between the three genotypes ( Table 2) . Furthermore, none of the genotypes defined by the 1080C?T polymorphism showed an association with elevated fasting, post-load or delta homocysteine concentration ( Table 2) . The different GT STR genotypes were also not associated with a change in plasma homocysteine concentrations (Table 2) . We also investigated the association between these three genetic variants and the 31 bp VNTR, of which alleles 19 and 21 were shown to be associated with increased post-methionine load homocysteine concentrations. 23 The positive association between alleles 19 and 21
and post-load homocysteine concentrations was however not reflected in one of the genotypes defined by the three variants studied here. We examined whether alleles 19 and 21 were located on particular haplotypes, but found out that this was not the case; six different haplotypes were observed containing allele 19, and three containing allele 21 (Table 3) . Linkage disequilibria were calculated between the 699C?T, 1080C?T and the GT STR and all were found to be highly significant (P50.001; data not shown). All pairwise linkage disequilibria between the different CBS alleles are depicted in Table 4 .
Discussion
In the present study, we investigated the potential involvement of variants in non-coding regions or silent mutations in the CBS gene by analysing the 699C?T and 1080C?T variants and a GT STR, which is located in the promotor region, as markers of possible genetic CBS defects contributing to hyperhomocysteinaemia and to the risk of arterial occlusive disease. No differences in genotype distributions or allele frequencies were found between cases and controls, indicating that no particular CBS genotype is over-represented in arterial occlusive disease patients compared with controls. We investigated the associations between CBS genotypes and plasma homocysteine concentrations, especially after methionine loading. The two silent mutations as well as the GT STR did not show an association with homocysteine concentrations, neither fasting, nor postload, nor on the increase upon methionine loading.
Besides fasting plasma homocysteine concentrations, 1, 18 also post-methionine load homocysteine concentrations have been associated with an increased CVD risk. reported decreased post-methionine load homocysteine concentrations in individuals who were heterozygous or homozygous for the 699T allele compared with the 699CC subjects. This association became more significant when individuals carrying the 844ins68 and the 1080T allele were excluded. With regard to the 1080C?T polymorphism, the 1080T allele was associated with lower post-methionine load homocysteine levels only when individuals carrying the 844ins68 and the 699T allele were excluded from the analysis. They also speculated that the 699C?T and 1080C?T CBS variants may be in linkage disequilibrium with regulatory elements that upregulate CBS gene transcription. 37 In the current study however, the two silent polymorphisms as well as the GT STR did not show any association with homocysteine concentrations, neither fasting, nor post-load, nor on the increase upon methionine loading. Both etiologic and genetic heterogeneity may play an important role in genetic association studies. Since the populations used in the different studies may have a different background, it is possible that the actual range of etiologies vary across samples. Allele frequencies of the 699C?T and 1080C?T polymorphisms were comparable between the three studies published earlier 35 -37 and the present one, ranging from 31.8 to 39.4% for the 699T allele and from 32.4 to 35.5% for the 1080T allele. We also investigated the association between these three genetic variants and the 31 bp VNTR, of which the alleles containing 19 and 21 repeat units were shown to be associated with increased post-methionine load homocysteine concentrations. 23 However, this positive association between alleles 19 and 21 and post-load homocysteine concentrations was not reflected in one of the genotypes defined by the three variants studied here. One explanation is that alleles 19 and 21 are rare (allele frequencies of 10.5 and 2.7%, respectively) and are therefore not picked up by a genetic association analysis described here. Furthermore, we observed that alleles 19 and 21 were both not located on one particular haplotype, but that different haplotypes were observed containing allele 19, which was also the case for allele 21 (Table 3) .
In the present study, we detected strong linkage disequilibria between the CBS variants studied. For each pair of alleles, defined by the three CBS variants, linkage disequilibrium coefficients (D') were calculated (Table 4) . D' between the 699C?T and the 1080C?T polymorphisms of 70.75 in our study is similar to that calculated by De Stephano et al 36 of 70.83 in almost 800 subjects recruited from 11 European countries.
In conclusion, we did not find any genotype, defined by the three CBS variants studied here, associated with elevated homocysteine concentrations. Although we observed strong linkage between these three polymorphisms, no evidence for a common CBS polymorphism leading to elevated homocysteine concentrations and increased CVD risk was found.
